HIGH-DOSE CHEMOTHERAPY PLUS AUTOLOGOUS STEM CELL TRANSPLANTATION COMPARED WITH INTERMEDIATE-DOSE CHEMOTHERAPY PLUS AUTOLOGOUS STEM CELL TRANSPLANTATION WITH OR WITHOUT ISOTRETINOIN IN TREATING YOUNG PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS: